SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004091
Filing Date
2021-11-10
Accepted
2021-11-10 16:18:12
Documents
76
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q atha-20210930.htm   iXBRL 10-Q 3270130
2 EX-31.1 atha-ex31_1.htm EX-31.1 15570
3 EX-31.2 atha-ex31_2.htm EX-31.2 15452
4 EX-32.1 atha-ex32_1.htm EX-32.1 11190
5 EX-32.2 atha-ex32_2.htm EX-32.2 9877
6 GRAPHIC img103399652_0.jpg GRAPHIC 142347
  Complete submission text file 0000950170-21-004091.txt   10743474

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT atha-20210930_def.xml EX-101.DEF 196471
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT atha-20210930.xsd EX-101.SCH 67079
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT atha-20210930_cal.xml EX-101.CAL 43679
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT atha-20210930_lab.xml EX-101.LAB 494760
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT atha-20210930_pre.xml EX-101.PRE 349361
12 EXTRACTED XBRL INSTANCE DOCUMENT atha-20210930_htm.xml XML 1959749
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39503 | Film No.: 211396901
SIC: 2836 Biological Products, (No Diagnostic Substances)